{
    "nct_id": "NCT02946008",
    "official_title": "A Phase I Trial of Neoadjuvant Stereotactic Body Radiotherapy Prior to Radical Prostatectomy for High Risk Prostate Cancer",
    "inclusion_criteria": "* Subjects must have biopsy-confirmed adenocarcinoma of the prostate.\n* Subjects must have a negative bone scan.\n* Subjects must have one of the following risk factors:\n* PSA ≥20 and/or\n* Gleason score ≥8 and/or\n* Clinical or radiographic stage ≥T3a per AJCC (American Joint Committee on Cancer) 7th Edition Staging Manual and/or\n* Radiographic pelvic lymph node positive disease and/or\n* At least two out of four of the following: PSA (Prostate Specific Antigen) 10-19.9, GS (Gleason Score) = 3+4, clinical stage = T2b/T2c, ≥50% positive biopsy cores.\n* Subjects must freely sign informed consent to enroll in the study.\n* Subjects must be medically fit to undergo surgery determined by the PI.\n* Age ≥ 18\n* KPS Karnofsky Performance Status (performance status is an attempt to quantify cancer patients' general well-being and activities of daily life, scores range from 0 to 100 where 100 represents perfect health and 0 represents death): ≥70.\n* No prior invasive malignancy in the past 3-years, except non-melanomatous skin cancer unless disease free for a minimum of 2 years. Carcinoma in-situ of the bladder or head and neck region is permissible.\n* Subjects must not have had prior pelvic radiation therapy,\n* Subjects must not have had prior androgen deprivation therapy in the past 6 months.\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Metastatic disease as demonstrated by bone scan, CT scan or MRI (Magnetic Resonance Imaging) of the pelvis, or chest x-ray.\n* Declared high-risk for anesthesia by attending anesthesiologist, cardiologist, or other physician.\n* History of prior pelvic radiation therapy.\n* History of androgen deprivation therapy within the past 6 months.",
    "miscellaneous_criteria": ""
}